BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, July 3, 2026
Breaking News: Science fiction realized: BCI tech is here
See today's BioWorld Science
Home
» Beijing Earthwise Technology discovers new E3 ligase/VAV1 interaction inducers
To read the full story,
subscribe
or
sign in
.
Cancer
Beijing Earthwise Technology discovers new E3 ligase/VAV1 interaction inducers
June 29, 2026
Beijing Earthwise Technology Co. Ltd. has patented new molecular glue degraders comprising an E3 ubiquitin-protein ligase-binding moiety acting as E3 ligase/proto-oncogene Vav (VAV1) interaction inducers and VAV1 degradation inducers.
BioWorld Science
Cancer
Degradation inducer
Patents